The GLP-1 drugs continue to make headlines due to their FDA-approved uses for treating Type 2 diabetes and obesity, but a ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.

Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...

It is possible to mimic the effect of GLP-1 in the body to boost weight loss with the right kind of diet. Read weight loss ...

Danish pharmaceutical leader Novo Nordisk (NYSE: NVO) is the brains behind Ozempic, as well as sibling GLP-1 medications ...

SHOPPING: Achieve your weight goals in 2025 with help from this potent polyphenol blend that boosts your natural production ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Lithocholic acid (LCA), a metabolite induced by calorie restriction (CR), activates AMPK and mimics anti-aging benefits. A ...

According to Ian Neeland, MD, strategies like pharmacist-led counseling, patient education programs, and patient assistance ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...